home / stock / gkos / gkos articles

GKOS Articles, Glaukos Corporation

Stock Information
Company Name: Glaukos Corporation
Stock Symbol: GKOS
Market: NYSE
Website: glaukos.com
Menu
GKOS GKOS Quote GKOS Short GKOS News GKOS Articles GKOS Message Board
Get GKOS Alerts

News, Short Squeeze, Breakout and More Instantly...
Will WATCHMAN Sales Aid Boston Scientific's Q2 Earnings? | Benzinga

Boston Scientific Corporation (NYSE: BSX) is scheduled to report second-quarter 2024 results on Jul 24, before the opening bell. In the last r...
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...

Here's Why You Should Retain Glaukos Stock for Now | Benzinga

Glaukos Corporation (NYSE: GKOS) is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, ...

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst | Benzinga

Thursday, Glaukos Corporation (NYSE:GKOS) reported a first-quarter adjusted EPS loss of $(0.70), up from $(0.59) a year ago, missing the&...
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday. Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sh...

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet Jewelers Limited (NYSE: SIG) rose sharply during ...

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst | Benzinga

Shares of Glaukos Corp (NYSE: GKOS) continued to climb in early trading on Thursday, after the company’s iDose TR (travoprost intracameral im...

Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

iDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst | Benzinga

Thursday, the FDA approved Glaukos Corporation's (NYSE: GKOS) marketing application for a single administration per eye of iDose TR (...
Next 10